Similarly, COL3A1 has been implicated in the progression of hepatocellular carcinoma and glioblastoma, with its overexpression correlating with poor prognosis and enhanced tumor aggressiveness [72, 73]. This evidence concerns the gene COL3A1 and hepatocellular carcinoma.